Correlation Between Kool2play and Medicofarma Biotech
Can any of the company-specific risk be diversified away by investing in both Kool2play and Medicofarma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kool2play and Medicofarma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kool2play SA and Medicofarma Biotech SA, you can compare the effects of market volatilities on Kool2play and Medicofarma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kool2play with a short position of Medicofarma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kool2play and Medicofarma Biotech.
Diversification Opportunities for Kool2play and Medicofarma Biotech
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kool2play and Medicofarma is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Kool2play SA and Medicofarma Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicofarma Biotech and Kool2play is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kool2play SA are associated (or correlated) with Medicofarma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicofarma Biotech has no effect on the direction of Kool2play i.e., Kool2play and Medicofarma Biotech go up and down completely randomly.
Pair Corralation between Kool2play and Medicofarma Biotech
Assuming the 90 days trading horizon Kool2play SA is expected to under-perform the Medicofarma Biotech. In addition to that, Kool2play is 1.38 times more volatile than Medicofarma Biotech SA. It trades about -0.02 of its total potential returns per unit of risk. Medicofarma Biotech SA is currently generating about -0.02 per unit of volatility. If you would invest 112.00 in Medicofarma Biotech SA on August 28, 2024 and sell it today you would lose (71.00) from holding Medicofarma Biotech SA or give up 63.39% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 89.69% |
Values | Daily Returns |
Kool2play SA vs. Medicofarma Biotech SA
Performance |
Timeline |
Kool2play SA |
Medicofarma Biotech |
Kool2play and Medicofarma Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kool2play and Medicofarma Biotech
The main advantage of trading using opposite Kool2play and Medicofarma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kool2play position performs unexpectedly, Medicofarma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will offset losses from the drop in Medicofarma Biotech's long position.Kool2play vs. Clean Carbon Energy | Kool2play vs. ADX | Kool2play vs. Agroliga Group PLC | Kool2play vs. Vee SA |
Medicofarma Biotech vs. Clean Carbon Energy | Medicofarma Biotech vs. ADX | Medicofarma Biotech vs. Agroliga Group PLC | Medicofarma Biotech vs. Vee SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bonds Directory Find actively traded corporate debentures issued by US companies |